Publications | Lund University Publications

51 – 60 of 67

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%220959-8049%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
…
4
5
6
7
next »

2000
Mark Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
Bratt, O ^LU ; Damber, J E ; Emanuelsson, M ; Kristoffersson, U ^LU ; Lundgren, R ; Olsson, Håkan ^LU and Grönberg, H (2000) In European Journal of Cancer 36(2). p.235-241
- Contribution to journal › Article
Mark Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer
Jönsson, M ^LU ; Borg, A ^LU ; Nilbert, M ^LU and Andersson, T ^LU (2000) In European Journal of Cancer 36(2). p.8-242
- Contribution to journal › Article
Mark Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group
Hakamies-Blomqvist, L ; Luoma, M ; Sjöström, J ; Pluzanska, A ; Sjödin, M ; Mouridsen, H ; Ostenstad, B ; Mjaaland, I ; Ottosson-Lönn, S and Bergh, J , et al. (2000) In European Journal of Cancer 36(11). p.7-1411
- Contribution to journal › Article
1999
Mark Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study
Bratt, O ^LU ; Kristoffersson, U ^LU ; Lundgren, R and Olsson, Håkan ^LU (1999) In European Journal of Cancer 35(2). p.7-272
- Contribution to journal › Article
Mark Rationale for randomised trials of prostate cancer screening
Alexander, F. E. (1999) In European Journal of Cancer 35(2). p.262-271
- Contribution to journal › Scientific review
1998
Mark Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
Jungnelius, U ; Ringborg, U ; Aamdal, S ; Mattsson, J ; Stierner, U ; Ingvar, C ^LU ; Malmström, P ^LU ; Andersson, R ; Karlsson, M and Willman, K , et al. (1998) In European Journal of Cancer 34(9). p.1368-1374
- Contribution to journal › Article
1997
Mark The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer : a population-based cohort study
Bratt, O ^LU ; Kristoffersson, U ^LU ; Lundgren, R and Olsson, Håkan ^LU (1997) In European Journal of Cancer 33(13). p.2237-2240
- Contribution to journal › Article
Mark Tumour biological features of BRCA1-induced breast and ovarian cancer
Jóhannsson, O T ^LU ; Idvall, I ^LU ; Anderson, C ; Borg, Åke ^LU ; Barkardóttir, R B ; Egilsson, V and Olsson, Håkan ^LU (1997) In European Journal of Cancer 33(3). p.362-371
- Contribution to journal › Article
1995
Mark The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas
Axelson, H ^LU ; Henriksson, M ^LU ; Wang, Y ^LU ; Magnusson, K P and Klein, G (1995) In European Journal of Cancer 31A(12). p.104-2099
- Contribution to journal › Article
1994
Mark Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line
Imreh, S ; Wang, Y ; Panda, C K ; Babonits, M ; Axelson, H ^LU ; Silva, S ; Szeles, A ; Wiener, F and Klein, G (1994) In European Journal of Cancer 30A(7). p.994-1002
- Contribution to journal › Article

« previous
1
2
…
4
5
6
7
next »

your query:: Remove issn: 0959-8049